Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASHP information on off-label uses

Executive Summary

On Feb. 24, the American Society of Hospital Pharmacists gave FDA's Medicine Staff a list of off-label uses of six products. Responding to an FDA request, ASHP's Speciality Practice Groups provided references to supporting literature on the uses of: paclitaxel for, metastatic breast cancer; cisplatin for lung cancer; cytarabine for non-Hodgkin's lymphoma; carbamazepine for bipolar mood disorders; valproic acid for bipolar mood disorders; and aminoglycoside antibiotics for once-daily administration. A study by Bowden et al. in the March 23 Journal of the American Medical Association, showed that Abbott's Depakote (divalproex sodium) is as effective as lithium (the only drug approved for treating mania) in the treatment of acute mania
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel